nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—ABCB1—peripheral nervous system neoplasm	0.167	1	CbGaD
Cabazitaxel—TUBA4A—Vincristine—peripheral nervous system neoplasm	0.109	0.163	CbGbCtD
Cabazitaxel—TUBB3—Vincristine—peripheral nervous system neoplasm	0.0499	0.0746	CbGbCtD
Cabazitaxel—TUBB6—Vincristine—peripheral nervous system neoplasm	0.0499	0.0746	CbGbCtD
Cabazitaxel—TUBB2A—Vincristine—peripheral nervous system neoplasm	0.0499	0.0746	CbGbCtD
Cabazitaxel—TUBB8—Vincristine—peripheral nervous system neoplasm	0.0499	0.0746	CbGbCtD
Cabazitaxel—TUBB4A—Vincristine—peripheral nervous system neoplasm	0.0499	0.0746	CbGbCtD
Cabazitaxel—TUBB2B—Vincristine—peripheral nervous system neoplasm	0.0499	0.0746	CbGbCtD
Cabazitaxel—TUBB—Vincristine—peripheral nervous system neoplasm	0.0417	0.0624	CbGbCtD
Cabazitaxel—TUBB4B—Vincristine—peripheral nervous system neoplasm	0.0417	0.0624	CbGbCtD
Cabazitaxel—TUBB1—Vincristine—peripheral nervous system neoplasm	0.0417	0.0624	CbGbCtD
Cabazitaxel—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0193	0.0288	CbGbCtD
Cabazitaxel—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0134	0.02	CbGbCtD
Cabazitaxel—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.00994	0.0149	CbGbCtD
Cabazitaxel—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.00956	0.0143	CbGbCtD
Cabazitaxel—ABCG2—Vincristine—peripheral nervous system neoplasm	0.00824	0.0123	CbGbCtD
Cabazitaxel—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.00769	0.0115	CbGbCtD
Cabazitaxel—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00755	0.0113	CbGbCtD
Cabazitaxel—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00696	0.0104	CbGbCtD
Cabazitaxel—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00696	0.0104	CbGbCtD
Cabazitaxel—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00515	0.00769	CbGbCtD
Cabazitaxel—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00483	0.00721	CbGbCtD
Cabazitaxel—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.00457	0.00682	CbGbCtD
Cabazitaxel—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00418	0.00625	CbGbCtD
Cabazitaxel—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00417	0.00623	CbGbCtD
Cabazitaxel—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00402	0.00601	CbGbCtD
Cabazitaxel—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00388	0.00579	CbGbCtD
Cabazitaxel—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00297	0.00444	CbGbCtD
Cabazitaxel—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00277	0.00414	CbGbCtD
Cabazitaxel—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00272	0.00407	CbGbCtD
Cabazitaxel—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00186	0.00277	CbGbCtD
Cabazitaxel—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00178	0.00266	CbGbCtD
Cabazitaxel—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00163	0.00244	CbGbCtD
Cabazitaxel—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00166	CbGbCtD
Cabazitaxel—TUBB6—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.000542	0.151	CbGdCrCtD
Cabazitaxel—TUBB6—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.000542	0.151	CbGdCrCtD
Cabazitaxel—Paclitaxel—ABCB1—peripheral nervous system neoplasm	0.000534	0.5	CrCbGaD
Cabazitaxel—Docetaxel—ABCB1—peripheral nervous system neoplasm	0.000534	0.5	CrCbGaD
Cabazitaxel—TUBB6—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.000411	0.115	CbGdCrCtD
Cabazitaxel—TUBB6—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000379	0.106	CbGdCrCtD
Cabazitaxel—TUBB6—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000379	0.106	CbGdCrCtD
Cabazitaxel—TUBB6—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000379	0.106	CbGdCrCtD
Cabazitaxel—TUBB6—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000379	0.106	CbGdCrCtD
Cabazitaxel—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00035	0.0343	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000297	0.0291	CbGpPWpGaD
Cabazitaxel—TUBB6—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000287	0.0801	CbGdCrCtD
Cabazitaxel—TUBB6—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000287	0.0801	CbGdCrCtD
Cabazitaxel—ABCG2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000275	0.0269	CbGpPWpGaD
Cabazitaxel—ABCG2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000271	0.0265	CbGpPWpGaD
Cabazitaxel—TUBB2B—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000236	0.0231	CbGpPWpGaD
Cabazitaxel—TUBB6—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000236	0.0231	CbGpPWpGaD
Cabazitaxel—TUBB3—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000228	0.0223	CbGpPWpGaD
Cabazitaxel—TUBB2A—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000221	0.0216	CbGpPWpGaD
Cabazitaxel—TUBB1—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000216	0.0211	CbGpPWpGaD
Cabazitaxel—CYP3A5—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000197	0.0193	CbGpPWpGaD
Cabazitaxel—TUBA4A—Regulation of PLK1 Activity at G2/M Transition—AURKA—peripheral nervous system neoplasm	0.000195	0.0191	CbGpPWpGaD
Cabazitaxel—TUBB4A—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000194	0.019	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000191	0.0187	CbGpPWpGaD
Cabazitaxel—TUBA4A—trigeminal ganglion—peripheral nervous system neoplasm	0.000177	0.0651	CbGeAlD
Cabazitaxel—TUBB4B—Orphan transporters—COX2—peripheral nervous system neoplasm	0.000177	0.0174	CbGpPWpGaD
Cabazitaxel—TUBA4A—parotid gland—peripheral nervous system neoplasm	0.000167	0.0614	CbGeAlD
Cabazitaxel—TUBB—Regulation of PLK1 Activity at G2/M Transition—AURKA—peripheral nervous system neoplasm	0.000166	0.0162	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.000165	0.0162	CbGpPWpGaD
Cabazitaxel—TUBA4A—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.000157	0.0154	CbGpPWpGaD
Cabazitaxel—TUBA4A—brainstem—peripheral nervous system neoplasm	0.000157	0.0576	CbGeAlD
Cabazitaxel—TUBA4A—G2/M Transition—AURKA—peripheral nervous system neoplasm	0.000146	0.0143	CbGpPWpGaD
Cabazitaxel—TUBA4A—Mitotic G2-G2/M phases—AURKA—peripheral nervous system neoplasm	0.000144	0.0141	CbGpPWpGaD
Cabazitaxel—TUBB4A—trigeminal ganglion—peripheral nervous system neoplasm	0.000142	0.0522	CbGeAlD
Cabazitaxel—TUBA4A—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.000138	0.0135	CbGpPWpGaD
Cabazitaxel—TUBB4A—Regulation of PLK1 Activity at G2/M Transition—AURKA—peripheral nervous system neoplasm	0.000137	0.0135	CbGpPWpGaD
Cabazitaxel—TUBB2B—trigeminal ganglion—peripheral nervous system neoplasm	0.000137	0.0504	CbGeAlD
Cabazitaxel—TUBA4A—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.000131	0.0128	CbGpPWpGaD
Cabazitaxel—TUBB—trigeminal ganglion—peripheral nervous system neoplasm	0.00013	0.0477	CbGeAlD
Cabazitaxel—TUBB2B—parotid gland—peripheral nervous system neoplasm	0.00013	0.0476	CbGeAlD
Cabazitaxel—TUBB2A—trigeminal ganglion—peripheral nervous system neoplasm	0.000129	0.0475	CbGeAlD
Cabazitaxel—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000129	0.0126	CbGpPWpGaD
Cabazitaxel—TUBB6—trigeminal ganglion—peripheral nervous system neoplasm	0.000128	0.0468	CbGeAlD
Cabazitaxel—TUBB4A—brainstem—peripheral nervous system neoplasm	0.000126	0.0462	CbGeAlD
Cabazitaxel—TUBB4B—Regulation of PLK1 Activity at G2/M Transition—AURKA—peripheral nervous system neoplasm	0.000126	0.0123	CbGpPWpGaD
Cabazitaxel—TUBB—G2/M Transition—AURKA—peripheral nervous system neoplasm	0.000125	0.0122	CbGpPWpGaD
Cabazitaxel—TUBB—Mitotic G2-G2/M phases—AURKA—peripheral nervous system neoplasm	0.000123	0.012	CbGpPWpGaD
Cabazitaxel—TUBB—parotid gland—peripheral nervous system neoplasm	0.000123	0.045	CbGeAlD
Cabazitaxel—TUBB2A—parotid gland—peripheral nervous system neoplasm	0.000122	0.0448	CbGeAlD
Cabazitaxel—TUBB6—parotid gland—peripheral nervous system neoplasm	0.00012	0.0442	CbGeAlD
Cabazitaxel—TUBB4B—trigeminal ganglion—peripheral nervous system neoplasm	0.000111	0.0407	CbGeAlD
Cabazitaxel—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000108	0.0106	CbGpPWpGaD
Cabazitaxel—TUBB4B—parotid gland—peripheral nervous system neoplasm	0.000105	0.0384	CbGeAlD
Cabazitaxel—TUBB4A—G2/M Transition—AURKA—peripheral nervous system neoplasm	0.000103	0.0101	CbGpPWpGaD
Cabazitaxel—TUBB3—cerebellum—peripheral nervous system neoplasm	0.000102	0.0374	CbGeAlD
Cabazitaxel—TUBB4A—Mitotic G2-G2/M phases—AURKA—peripheral nervous system neoplasm	0.000102	0.00997	CbGpPWpGaD
Cabazitaxel—TUBB4B—G2/M Transition—AURKA—peripheral nervous system neoplasm	9.44e-05	0.00924	CbGpPWpGaD
Cabazitaxel—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	9.36e-05	0.00064	CcSEcCtD
Cabazitaxel—Dry skin—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.000638	CcSEcCtD
Cabazitaxel—Chest pain—Etoposide—peripheral nervous system neoplasm	9.32e-05	0.000637	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000636	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	9.31e-05	0.000636	CcSEcCtD
Cabazitaxel—TUBB4B—Mitotic G2-G2/M phases—AURKA—peripheral nervous system neoplasm	9.31e-05	0.00911	CbGpPWpGaD
Cabazitaxel—Anorexia—Cisplatin—peripheral nervous system neoplasm	9.3e-05	0.000635	CcSEcCtD
Cabazitaxel—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	9.28e-05	0.000634	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	9.26e-05	0.000633	CcSEcCtD
Cabazitaxel—Discomfort—Etoposide—peripheral nervous system neoplasm	9.21e-05	0.000629	CcSEcCtD
Cabazitaxel—Breast disorder—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000629	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000627	CcSEcCtD
Cabazitaxel—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	9.16e-05	0.00896	CbGpPWpGaD
Cabazitaxel—Hypotension—Cisplatin—peripheral nervous system neoplasm	9.12e-05	0.000623	CcSEcCtD
Cabazitaxel—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	9.1e-05	0.000622	CcSEcCtD
Cabazitaxel—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	9.05e-05	0.000618	CcSEcCtD
Cabazitaxel—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	9.05e-05	0.000618	CcSEcCtD
Cabazitaxel—Nausea—Topotecan—peripheral nervous system neoplasm	9.05e-05	0.000618	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	9.02e-05	0.000616	CcSEcCtD
Cabazitaxel—Gastritis—Epirubicin—peripheral nervous system neoplasm	9.02e-05	0.000616	CcSEcCtD
Cabazitaxel—Confusional state—Etoposide—peripheral nervous system neoplasm	9.01e-05	0.000616	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	8.99e-05	0.000614	CcSEcCtD
Cabazitaxel—Nausea—Tretinoin—peripheral nervous system neoplasm	8.97e-05	0.000613	CcSEcCtD
Cabazitaxel—Nausea—Isotretinoin—peripheral nervous system neoplasm	8.97e-05	0.000613	CcSEcCtD
Cabazitaxel—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	8.97e-05	0.000613	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	8.89e-05	0.000607	CcSEcCtD
Cabazitaxel—Infection—Etoposide—peripheral nervous system neoplasm	8.88e-05	0.000607	CcSEcCtD
Cabazitaxel—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.000606	CcSEcCtD
Cabazitaxel—Asthenia—Dactinomycin—peripheral nervous system neoplasm	8.86e-05	0.000605	CcSEcCtD
Cabazitaxel—Nausea—Melphalan—peripheral nervous system neoplasm	8.86e-05	0.000605	CcSEcCtD
Cabazitaxel—Influenza—Epirubicin—peripheral nervous system neoplasm	8.81e-05	0.000602	CcSEcCtD
Cabazitaxel—Dehydration—Doxorubicin—peripheral nervous system neoplasm	8.77e-05	0.000599	CcSEcCtD
Cabazitaxel—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	8.76e-05	0.000598	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	8.75e-05	0.000598	CcSEcCtD
Cabazitaxel—Tachycardia—Etoposide—peripheral nervous system neoplasm	8.72e-05	0.000596	CcSEcCtD
Cabazitaxel—Abdominal pain—Vincristine—peripheral nervous system neoplasm	8.72e-05	0.000596	CcSEcCtD
Cabazitaxel—Body temperature increased—Vincristine—peripheral nervous system neoplasm	8.72e-05	0.000596	CcSEcCtD
Cabazitaxel—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	8.7e-05	0.000594	CcSEcCtD
Cabazitaxel—Skin disorder—Etoposide—peripheral nervous system neoplasm	8.68e-05	0.000593	CcSEcCtD
Cabazitaxel—Dry skin—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000591	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000589	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	8.61e-05	0.000589	CcSEcCtD
Cabazitaxel—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	8.58e-05	0.000586	CcSEcCtD
Cabazitaxel—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000582	CcSEcCtD
Cabazitaxel—Anorexia—Etoposide—peripheral nervous system neoplasm	8.52e-05	0.000582	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	8.49e-05	0.00058	CcSEcCtD
Cabazitaxel—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	8.48e-05	0.000579	CcSEcCtD
Cabazitaxel—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	8.45e-05	0.000577	CcSEcCtD
Cabazitaxel—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	8.44e-05	0.000576	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	8.42e-05	0.000575	CcSEcCtD
Cabazitaxel—Hypotension—Etoposide—peripheral nervous system neoplasm	8.35e-05	0.000571	CcSEcCtD
Cabazitaxel—Gastritis—Doxorubicin—peripheral nervous system neoplasm	8.35e-05	0.00057	CcSEcCtD
Cabazitaxel—Pain—Cisplatin—peripheral nervous system neoplasm	8.34e-05	0.00057	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	8.32e-05	0.000568	CcSEcCtD
Cabazitaxel—Neutropenia—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000563	CcSEcCtD
Cabazitaxel—Dysuria—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000563	CcSEcCtD
Cabazitaxel—Asthenia—Alitretinoin—peripheral nervous system neoplasm	8.22e-05	0.000561	CcSEcCtD
Cabazitaxel—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000561	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	8.19e-05	0.000559	CcSEcCtD
Cabazitaxel—Influenza—Doxorubicin—peripheral nervous system neoplasm	8.15e-05	0.000557	CcSEcCtD
Cabazitaxel—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	8.14e-05	0.000556	CcSEcCtD
Cabazitaxel—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	8.13e-05	0.000555	CcSEcCtD
Cabazitaxel—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	8.04e-05	0.000549	CcSEcCtD
Cabazitaxel—Paraesthesia—Etoposide—peripheral nervous system neoplasm	8.03e-05	0.000548	CcSEcCtD
Cabazitaxel—Weight decreased—Epirubicin—peripheral nervous system neoplasm	7.97e-05	0.000545	CcSEcCtD
Cabazitaxel—Dyspnoea—Etoposide—peripheral nervous system neoplasm	7.97e-05	0.000544	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	7.95e-05	0.000543	CcSEcCtD
Cabazitaxel—Asthenia—Vincristine—peripheral nervous system neoplasm	7.92e-05	0.000541	CcSEcCtD
Cabazitaxel—Pneumonia—Epirubicin—peripheral nervous system neoplasm	7.9e-05	0.00054	CcSEcCtD
Cabazitaxel—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	7.86e-05	0.000537	CcSEcCtD
Cabazitaxel—Infestation—Epirubicin—peripheral nervous system neoplasm	7.86e-05	0.000537	CcSEcCtD
Cabazitaxel—Vomiting—Dactinomycin—peripheral nervous system neoplasm	7.85e-05	0.000536	CcSEcCtD
Cabazitaxel—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	7.83e-05	0.000535	CcSEcCtD
Cabazitaxel—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.77e-05	0.000531	CcSEcCtD
Cabazitaxel—TUBA4A—cerebellum—peripheral nervous system neoplasm	7.74e-05	0.0284	CbGeAlD
Cabazitaxel—Renal failure—Epirubicin—peripheral nervous system neoplasm	7.72e-05	0.000528	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	7.72e-05	0.000527	CcSEcCtD
Cabazitaxel—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.71e-05	0.000527	CcSEcCtD
Cabazitaxel—Fatigue—Etoposide—peripheral nervous system neoplasm	7.71e-05	0.000526	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	7.7e-05	0.000526	CcSEcCtD
Cabazitaxel—CYP3A5—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	7.66e-05	0.0075	CbGpPWpGaD
Cabazitaxel—Pain—Etoposide—peripheral nervous system neoplasm	7.64e-05	0.000522	CcSEcCtD
Cabazitaxel—Constipation—Etoposide—peripheral nervous system neoplasm	7.64e-05	0.000522	CcSEcCtD
Cabazitaxel—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000522	CcSEcCtD
Cabazitaxel—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	7.64e-05	0.000522	CcSEcCtD
Cabazitaxel—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.000521	CcSEcCtD
Cabazitaxel—Dysuria—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.000521	CcSEcCtD
Cabazitaxel—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	7.6e-05	0.00744	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	7.58e-05	0.00743	CbGpPWpGaD
Cabazitaxel—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.000518	CcSEcCtD
Cabazitaxel—Dizziness—Alitretinoin—peripheral nervous system neoplasm	7.57e-05	0.000517	CcSEcCtD
Cabazitaxel—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.55e-05	0.000516	CcSEcCtD
Cabazitaxel—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.000514	CcSEcCtD
Cabazitaxel—Haematuria—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.000512	CcSEcCtD
Cabazitaxel—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	7.37e-05	0.000504	CcSEcCtD
Cabazitaxel—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	7.37e-05	0.000503	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.000502	CcSEcCtD
Cabazitaxel—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.34e-05	0.000501	CcSEcCtD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	7.33e-05	0.00717	CbGpPWpGaD
Cabazitaxel—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	7.31e-05	0.000499	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.31e-05	0.000499	CcSEcCtD
Cabazitaxel—Dizziness—Vincristine—peripheral nervous system neoplasm	7.3e-05	0.000498	CcSEcCtD
Cabazitaxel—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.28e-05	0.000497	CcSEcCtD
Cabazitaxel—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	7.27e-05	0.000497	CcSEcCtD
Cabazitaxel—Infestation—Doxorubicin—peripheral nervous system neoplasm	7.27e-05	0.000497	CcSEcCtD
Cabazitaxel—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	7.19e-05	0.000491	CcSEcCtD
Cabazitaxel—Headache—Alitretinoin—peripheral nervous system neoplasm	7.17e-05	0.00049	CcSEcCtD
Cabazitaxel—Renal failure—Doxorubicin—peripheral nervous system neoplasm	7.14e-05	0.000488	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	7.12e-05	0.000487	CcSEcCtD
Cabazitaxel—Abdominal pain—Etoposide—peripheral nervous system neoplasm	7.07e-05	0.000483	CcSEcCtD
Cabazitaxel—Body temperature increased—Etoposide—peripheral nervous system neoplasm	7.07e-05	0.000483	CcSEcCtD
Cabazitaxel—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000483	CcSEcCtD
Cabazitaxel—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000483	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.000479	CcSEcCtD
Cabazitaxel—Vomiting—Vincristine—peripheral nervous system neoplasm	7.02e-05	0.000479	CcSEcCtD
Cabazitaxel—Asthenia—Cisplatin—peripheral nervous system neoplasm	7e-05	0.000478	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.000476	CcSEcCtD
Cabazitaxel—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000475	CcSEcCtD
Cabazitaxel—Haematuria—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000473	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	6.93e-05	0.000473	CcSEcCtD
Cabazitaxel—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	6.91e-05	0.000472	CcSEcCtD
Cabazitaxel—Headache—Vincristine—peripheral nervous system neoplasm	6.91e-05	0.000472	CcSEcCtD
Cabazitaxel—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.8e-05	0.000465	CcSEcCtD
Cabazitaxel—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.67e-05	0.000456	CcSEcCtD
Cabazitaxel—Eye disorder—Epirubicin—peripheral nervous system neoplasm	6.59e-05	0.00045	CcSEcCtD
Cabazitaxel—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.58e-05	0.00045	CcSEcCtD
Cabazitaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—peripheral nervous system neoplasm	6.58e-05	0.00645	CbGpPWpGaD
Cabazitaxel—Tinnitus—Epirubicin—peripheral nervous system neoplasm	6.57e-05	0.000449	CcSEcCtD
Cabazitaxel—Nausea—Vincristine—peripheral nervous system neoplasm	6.55e-05	0.000448	CcSEcCtD
Cabazitaxel—Flushing—Epirubicin—peripheral nervous system neoplasm	6.54e-05	0.000447	CcSEcCtD
Cabazitaxel—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	6.54e-05	0.000447	CcSEcCtD
Cabazitaxel—ABCG2—trigeminal ganglion—peripheral nervous system neoplasm	6.54e-05	0.024	CbGeAlD
Cabazitaxel—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	6.49e-05	0.000444	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.00044	CcSEcCtD
Cabazitaxel—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000439	CcSEcCtD
Cabazitaxel—Asthenia—Etoposide—peripheral nervous system neoplasm	6.41e-05	0.000438	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.000438	CcSEcCtD
Cabazitaxel—Angiopathy—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.000437	CcSEcCtD
Cabazitaxel—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	6.4e-05	0.000437	CcSEcCtD
Cabazitaxel—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	6.37e-05	0.000435	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000434	CcSEcCtD
Cabazitaxel—Chills—Epirubicin—peripheral nervous system neoplasm	6.33e-05	0.000432	CcSEcCtD
Cabazitaxel—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	6.3e-05	0.00043	CcSEcCtD
Cabazitaxel—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000426	CcSEcCtD
Cabazitaxel—Vomiting—Cisplatin—peripheral nervous system neoplasm	6.2e-05	0.000424	CcSEcCtD
Cabazitaxel—TUBB4A—cerebellum—peripheral nervous system neoplasm	6.2e-05	0.0228	CbGeAlD
Cabazitaxel—Mental disorder—Epirubicin—peripheral nervous system neoplasm	6.18e-05	0.000422	CcSEcCtD
Cabazitaxel—ABCG2—parotid gland—peripheral nervous system neoplasm	6.17e-05	0.0226	CbGeAlD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.16e-05	0.00603	CbGpPWpGaD
Cabazitaxel—Erythema—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000419	CcSEcCtD
Cabazitaxel—Malnutrition—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000419	CcSEcCtD
Cabazitaxel—Diarrhoea—Etoposide—peripheral nervous system neoplasm	6.12e-05	0.000418	CcSEcCtD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	6.1e-05	0.00598	CbGpPWpGaD
Cabazitaxel—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000417	CcSEcCtD
Cabazitaxel—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	6.08e-05	0.000416	CcSEcCtD
Cabazitaxel—Flushing—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000414	CcSEcCtD
Cabazitaxel—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	6.06e-05	0.000414	CcSEcCtD
Cabazitaxel—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.000411	CcSEcCtD
Cabazitaxel—TUBB2B—cerebellum—peripheral nervous system neoplasm	5.99e-05	0.022	CbGeAlD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	5.99e-05	0.00586	CbGpPWpGaD
Cabazitaxel—Back pain—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000406	CcSEcCtD
Cabazitaxel—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000404	CcSEcCtD
Cabazitaxel—Dizziness—Etoposide—peripheral nervous system neoplasm	5.91e-05	0.000404	CcSEcCtD
Cabazitaxel—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	5.9e-05	0.00578	CbGpPWpGaD
Cabazitaxel—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	5.9e-05	0.000403	CcSEcCtD
Cabazitaxel—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000403	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000402	CcSEcCtD
Cabazitaxel—Chills—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.0004	CcSEcCtD
Cabazitaxel—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	5.83e-05	0.000398	CcSEcCtD
Cabazitaxel—Nausea—Cisplatin—peripheral nervous system neoplasm	5.79e-05	0.000396	CcSEcCtD
Cabazitaxel—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.77e-05	0.000394	CcSEcCtD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.76e-05	0.00564	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.76e-05	0.00564	CbGpPWpGaD
Cabazitaxel—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000391	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.000389	CcSEcCtD
Cabazitaxel—Vomiting—Etoposide—peripheral nervous system neoplasm	5.68e-05	0.000388	CcSEcCtD
Cabazitaxel—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000388	CcSEcCtD
Cabazitaxel—Erythema—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000388	CcSEcCtD
Cabazitaxel—Anaemia—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000388	CcSEcCtD
Cabazitaxel—TUBB—cerebellum—peripheral nervous system neoplasm	5.67e-05	0.0208	CbGeAlD
Cabazitaxel—TUBB2A—cerebellum—peripheral nervous system neoplasm	5.64e-05	0.0207	CbGeAlD
Cabazitaxel—Headache—Etoposide—peripheral nervous system neoplasm	5.6e-05	0.000383	CcSEcCtD
Cabazitaxel—TUBB6—cerebellum—peripheral nervous system neoplasm	5.56e-05	0.0204	CbGeAlD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.56e-05	0.00545	CbGpPWpGaD
Cabazitaxel—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.00038	CcSEcCtD
Cabazitaxel—Malaise—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000378	CcSEcCtD
Cabazitaxel—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.52e-05	0.000377	CcSEcCtD
Cabazitaxel—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.49e-05	0.000375	CcSEcCtD
Cabazitaxel—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000375	CcSEcCtD
Cabazitaxel—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000373	CcSEcCtD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.39e-05	0.00528	CbGpPWpGaD
Cabazitaxel—Cough—Epirubicin—peripheral nervous system neoplasm	5.36e-05	0.000366	CcSEcCtD
Cabazitaxel—Nausea—Etoposide—peripheral nervous system neoplasm	5.31e-05	0.000363	CcSEcCtD
Cabazitaxel—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.3e-05	0.000362	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.00036	CcSEcCtD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.27e-05	0.00516	CbGpPWpGaD
Cabazitaxel—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000359	CcSEcCtD
Cabazitaxel—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000357	CcSEcCtD
Cabazitaxel—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000357	CcSEcCtD
Cabazitaxel—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000357	CcSEcCtD
Cabazitaxel—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.21e-05	0.000356	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.19e-05	0.000355	CcSEcCtD
Cabazitaxel—Discomfort—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000353	CcSEcCtD
Cabazitaxel—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.00035	CcSEcCtD
Cabazitaxel—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.11e-05	0.000349	CcSEcCtD
Cabazitaxel—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.1e-05	0.000349	CcSEcCtD
Cabazitaxel—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.000347	CcSEcCtD
Cabazitaxel—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.05e-05	0.000345	CcSEcCtD
Cabazitaxel—Oedema—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000342	CcSEcCtD
Cabazitaxel—Infection—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.00034	CcSEcCtD
Cabazitaxel—Cough—Doxorubicin—peripheral nervous system neoplasm	4.96e-05	0.000339	CcSEcCtD
Cabazitaxel—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000336	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000335	CcSEcCtD
Cabazitaxel—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.9e-05	0.000335	CcSEcCtD
Cabazitaxel—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.89e-05	0.000334	CcSEcCtD
Cabazitaxel—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.87e-05	0.000332	CcSEcCtD
Cabazitaxel—TUBB4B—cerebellum—peripheral nervous system neoplasm	4.84e-05	0.0178	CbGeAlD
Cabazitaxel—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.00033	CcSEcCtD
Cabazitaxel—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.00033	CcSEcCtD
Cabazitaxel—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.00033	CcSEcCtD
Cabazitaxel—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000329	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000328	CcSEcCtD
Cabazitaxel—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000326	CcSEcCtD
Cabazitaxel—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.78e-05	0.000326	CcSEcCtD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.73e-05	0.00463	CbGpPWpGaD
Cabazitaxel—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.000323	CcSEcCtD
Cabazitaxel—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.68e-05	0.00032	CcSEcCtD
Cabazitaxel—Confusional state—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000319	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	4.66e-05	0.00456	CbGpPWpGaD
Cabazitaxel—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000317	CcSEcCtD
Cabazitaxel—Infection—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000315	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000312	CcSEcCtD
Cabazitaxel—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.55e-05	0.000311	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.00031	CcSEcCtD
Cabazitaxel—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.52e-05	0.000309	CcSEcCtD
Cabazitaxel—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.5e-05	0.000308	CcSEcCtD
Cabazitaxel—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000307	CcSEcCtD
Cabazitaxel—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.47e-05	0.000305	CcSEcCtD
Cabazitaxel—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000302	CcSEcCtD
Cabazitaxel—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.000301	CcSEcCtD
Cabazitaxel—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.36e-05	0.000298	CcSEcCtD
Cabazitaxel—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.000296	CcSEcCtD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.33e-05	0.00424	CbGpPWpGaD
Cabazitaxel—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.33e-05	0.000296	CcSEcCtD
Cabazitaxel—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.32e-05	0.000295	CcSEcCtD
Cabazitaxel—Pain—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000293	CcSEcCtD
Cabazitaxel—Constipation—Epirubicin—peripheral nervous system neoplasm	4.28e-05	0.000293	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000289	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle—AURKA—peripheral nervous system neoplasm	4.17e-05	0.00408	CbGpPWpGaD
Cabazitaxel—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000284	CcSEcCtD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.14e-05	0.00405	CbGpPWpGaD
Cabazitaxel—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000282	CcSEcCtD
Cabazitaxel—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.000282	CcSEcCtD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	4.1e-05	0.00401	CbGpPWpGaD
Cabazitaxel—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.1e-05	0.00028	CcSEcCtD
Cabazitaxel—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.000279	CcSEcCtD
Cabazitaxel—TUBA4A—Hemostasis—IFNB1—peripheral nervous system neoplasm	4.07e-05	0.00399	CbGpPWpGaD
Cabazitaxel—SLCO1B3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	4.07e-05	0.00399	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.06e-05	0.00398	CbGpPWpGaD
Cabazitaxel—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.03e-05	0.000275	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000273	CcSEcCtD
Cabazitaxel—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4e-05	0.000273	CcSEcCtD
Cabazitaxel—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000271	CcSEcCtD
Cabazitaxel—Pain—Doxorubicin—peripheral nervous system neoplasm	3.96e-05	0.000271	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	3.96e-05	0.00388	CbGpPWpGaD
Cabazitaxel—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.96e-05	0.000271	CcSEcCtD
Cabazitaxel—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.96e-05	0.000271	CcSEcCtD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.91e-05	0.00383	CbGpPWpGaD
Cabazitaxel—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000261	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.79e-05	0.000259	CcSEcCtD
Cabazitaxel—TUBA4A—Hemostasis—KNG1—peripheral nervous system neoplasm	3.78e-05	0.0037	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—CHEK2—peripheral nervous system neoplasm	3.73e-05	0.00365	CbGpPWpGaD
Cabazitaxel—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.69e-05	0.000252	CcSEcCtD
Cabazitaxel—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.00025	CcSEcCtD
Cabazitaxel—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.00025	CcSEcCtD
Cabazitaxel—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.59e-05	0.000246	CcSEcCtD
Cabazitaxel—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	3.56e-05	0.00348	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—AURKA—peripheral nervous system neoplasm	3.54e-05	0.00347	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	3.44e-05	0.00337	CbGpPWpGaD
Cabazitaxel—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.43e-05	0.000234	CcSEcCtD
Cabazitaxel—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.000233	CcSEcCtD
Cabazitaxel—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	3.4e-05	0.00333	CbGpPWpGaD
Cabazitaxel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	3.39e-05	0.00332	CbGpPWpGaD
Cabazitaxel—TUBA4A—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	3.38e-05	0.00331	CbGpPWpGaD
Cabazitaxel—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.33e-05	0.000227	CcSEcCtD
Cabazitaxel—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000226	CcSEcCtD
Cabazitaxel—TUBA4A—Hemostasis—GNAS—peripheral nervous system neoplasm	3.3e-05	0.00323	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	3.28e-05	0.00321	CbGpPWpGaD
Cabazitaxel—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	3.22e-05	0.0118	CbGeAlD
Cabazitaxel—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.19e-05	0.000218	CcSEcCtD
Cabazitaxel—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.17e-05	0.000217	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle—CHEK2—peripheral nervous system neoplasm	3.17e-05	0.0031	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—HGF—peripheral nervous system neoplasm	3.15e-05	0.00308	CbGpPWpGaD
Cabazitaxel—Headache—Epirubicin—peripheral nervous system neoplasm	3.14e-05	0.000214	CcSEcCtD
Cabazitaxel—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000209	CcSEcCtD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.05e-05	0.00298	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.05e-05	0.00298	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	3.02e-05	0.00296	CbGpPWpGaD
Cabazitaxel—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.01e-05	0.00295	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	3e-05	0.00294	CbGpPWpGaD
Cabazitaxel—Nausea—Epirubicin—peripheral nervous system neoplasm	2.98e-05	0.000203	CcSEcCtD
Cabazitaxel—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.000201	CcSEcCtD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.94e-05	0.00288	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—AURKA—peripheral nervous system neoplasm	2.94e-05	0.00287	CbGpPWpGaD
Cabazitaxel—TUBB2B—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	2.9e-05	0.00284	CbGpPWpGaD
Cabazitaxel—TUBB6—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	2.9e-05	0.00284	CbGpPWpGaD
Cabazitaxel—Headache—Doxorubicin—peripheral nervous system neoplasm	2.9e-05	0.000198	CcSEcCtD
Cabazitaxel—ABCG2—cerebellum—peripheral nervous system neoplasm	2.85e-05	0.0105	CbGeAlD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.85e-05	0.00279	CbGpPWpGaD
Cabazitaxel—TUBB3—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	2.8e-05	0.00275	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.79e-05	0.00273	CbGpPWpGaD
Cabazitaxel—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.75e-05	0.000188	CcSEcCtD
Cabazitaxel—SLCO1B3—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.74e-05	0.00269	CbGpPWpGaD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.74e-05	0.00268	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.73e-05	0.00267	CbGpPWpGaD
Cabazitaxel—TUBB2A—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	2.72e-05	0.00266	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	2.7e-05	0.00264	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—AURKA—peripheral nervous system neoplasm	2.69e-05	0.00263	CbGpPWpGaD
Cabazitaxel—TUBB1—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	2.66e-05	0.0026	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.63e-05	0.00257	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CHEK2—peripheral nervous system neoplasm	2.63e-05	0.00257	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	2.57e-05	0.00252	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.53e-05	0.00247	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.5e-05	0.00245	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.45e-05	0.0024	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.45e-05	0.0024	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.43e-05	0.00238	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.41e-05	0.00236	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.41e-05	0.00236	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CHEK2—peripheral nervous system neoplasm	2.4e-05	0.00235	CbGpPWpGaD
Cabazitaxel—TUBB4A—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	2.38e-05	0.00234	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	2.38e-05	0.00233	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.37e-05	0.00232	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.32e-05	0.00228	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—BIRC5—peripheral nervous system neoplasm	2.3e-05	0.00225	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.3e-05	0.00225	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.29e-05	0.00225	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.29e-05	0.00224	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.28e-05	0.00223	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.25e-05	0.0022	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.24e-05	0.0022	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.2e-05	0.00216	CbGpPWpGaD
Cabazitaxel—TUBB4B—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	2.18e-05	0.00214	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	2.13e-05	0.00208	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.07e-05	0.00203	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.01e-05	0.00197	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	2e-05	0.00196	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GNS—peripheral nervous system neoplasm	1.98e-05	0.00194	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.98e-05	0.00194	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	1.95e-05	0.00191	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—BIRC5—peripheral nervous system neoplasm	1.9e-05	0.00186	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—NME1—peripheral nervous system neoplasm	1.9e-05	0.00186	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.84e-05	0.00181	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.84e-05	0.0018	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—COX2—peripheral nervous system neoplasm	1.83e-05	0.00179	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.81e-05	0.00177	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.81e-05	0.00177	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.79e-05	0.00175	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—BIRC5—peripheral nervous system neoplasm	1.74e-05	0.0017	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.73e-05	0.00169	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.71e-05	0.00167	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	1.7e-05	0.00167	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.69e-05	0.00165	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.66e-05	0.00163	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.65e-05	0.00161	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.63e-05	0.0016	CbGpPWpGaD
Cabazitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	1.63e-05	0.0016	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.57e-05	0.00154	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.54e-05	0.0015	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.53e-05	0.0015	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.52e-05	0.00149	CbGpPWpGaD
Cabazitaxel—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	1.42e-05	0.00139	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	1.41e-05	0.00138	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.41e-05	0.00138	CbGpPWpGaD
Cabazitaxel—ABCB1—cerebellum—peripheral nervous system neoplasm	1.41e-05	0.00516	CbGeAlD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.39e-05	0.00136	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—NRAS—peripheral nervous system neoplasm	1.38e-05	0.00135	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.37e-05	0.00134	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.36e-05	0.00133	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	1.33e-05	0.00131	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.31e-05	0.00129	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	1.29e-05	0.00126	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.29e-05	0.00126	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	1.28e-05	0.00125	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.26e-05	0.00123	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	1.23e-05	0.00121	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	1.23e-05	0.0012	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.22e-05	0.0012	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—MYC—peripheral nervous system neoplasm	1.21e-05	0.00119	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ENO2—peripheral nervous system neoplasm	1.2e-05	0.00118	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	1.18e-05	0.00116	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	1.15e-05	0.00113	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	1.15e-05	0.00113	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	1.14e-05	0.00112	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.12e-05	0.00109	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.1e-05	0.00107	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.06e-05	0.00104	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—peripheral nervous system neoplasm	1.06e-05	0.00103	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.04e-05	0.00101	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—MYC—peripheral nervous system neoplasm	1.03e-05	0.00101	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.02e-05	0.000995	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—BCHE—peripheral nervous system neoplasm	1.02e-05	0.000994	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.01e-05	0.000989	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—peripheral nervous system neoplasm	9.96e-06	0.000975	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.69e-06	0.000949	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	9.56e-06	0.000936	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—TH—peripheral nervous system neoplasm	9.55e-06	0.000935	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.23e-06	0.000904	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—AKT1—peripheral nervous system neoplasm	8.91e-06	0.000873	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	8.9e-06	0.000872	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	8.84e-06	0.000866	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	8.8e-06	0.000862	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	8.74e-06	0.000856	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—MYC—peripheral nervous system neoplasm	8.55e-06	0.000837	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	8.48e-06	0.00083	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—peripheral nervous system neoplasm	8.47e-06	0.000829	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.42e-06	0.000824	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	8.16e-06	0.000799	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	8.08e-06	0.000791	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—MYC—peripheral nervous system neoplasm	7.82e-06	0.000765	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—GNAS—peripheral nervous system neoplasm	7.8e-06	0.000763	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	7.74e-06	0.000758	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	7.66e-06	0.00075	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—ABCB1—peripheral nervous system neoplasm	7.65e-06	0.000749	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	7.48e-06	0.000732	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	7.34e-06	0.000719	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	7.07e-06	0.000692	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	7.03e-06	0.000688	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—peripheral nervous system neoplasm	7.02e-06	0.000687	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.96e-06	0.000681	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	6.82e-06	0.000668	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	6.67e-06	0.000653	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.51e-06	0.000637	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—peripheral nervous system neoplasm	6.42e-06	0.000629	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	6.42e-06	0.000628	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	6.4e-06	0.000626	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	6.32e-06	0.000619	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	6.16e-06	0.000603	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.03e-06	0.00059	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	5.94e-06	0.000582	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.69e-06	0.000557	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.6e-06	0.000548	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	5.49e-06	0.000537	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	5.36e-06	0.000525	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	5.24e-06	0.000513	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.14e-06	0.000503	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	4.85e-06	0.000475	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.76e-06	0.000466	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	4.64e-06	0.000454	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	4.53e-06	0.000443	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	4.51e-06	0.000441	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.32e-06	0.000423	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	4.26e-06	0.000417	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	4.11e-06	0.000403	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	4.04e-06	0.000396	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.94e-06	0.000386	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	3.92e-06	0.000384	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.81e-06	0.000373	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	3.79e-06	0.000372	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.74e-06	0.000366	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	3.69e-06	0.000361	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	3.47e-06	0.00034	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	3.42e-06	0.000334	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	3.41e-06	0.000334	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.26e-06	0.000319	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	3.21e-06	0.000314	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	3.01e-06	0.000295	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	2.95e-06	0.000289	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	2.62e-06	0.000257	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2.49e-06	0.000244	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	2.1e-06	0.000206	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKT1—peripheral nervous system neoplasm	2.1e-06	0.000206	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.01e-06	0.000197	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.98e-06	0.000194	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.62e-06	0.000158	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.59e-06	0.000155	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	1.41e-06	0.000138	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	1.31e-06	0.000128	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	9.38e-07	9.18e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	8.12e-07	7.95e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	7.08e-07	6.93e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	4.36e-07	4.27e-05	CbGpPWpGaD
